CD274 and gastric cancer: Studies reported that the selection of drug for new complementary chemotherapy does not have a uniform standard and not completely effective in all types of gastric cancer, and that immunotherapy, especially for PD‐1/PDL‐1 inhibitors, did not show good suitability for patients with gastric cancer.4, 5